- Articles

Multilevel Interventions in Health Care Conference: Welcome by Steven Clauser, PhD


>>>DR. STEVEN CLAUSER: Well,
good morning. I would really like to officially bring
this conference to order. My name is Steve Clauser. I am
co-chair of the conference and on behalf of the
National Cancer Institute, I really want to welcome you
to our Multi-Interventions in Health Care: Building
the Foundation for Future Research conference. I think
as you will see throughout the meeting, there are many
people that have made significant contributions
in the development of this conference, but to start it
out I really would like to acknowledge the contributions
of two senior leaders in our Division of Cancer Control
and Population Sciences here at NCI, both in terms of
their interest in the subject matter, and also their
financial support. Without their help, this
conference simply would not have happened. And so I
would like to acknowledge Dr. Rachel Ballard-Barbash
who is Associate Director of Applied Research Program,
as well as Bill Klein, who is Associate Director of the
Behavioral Research Program. Thank you very much
for your continued support
of this effort.>>>[APPLAUSE] I think as you will
soon appreciate, the field of multilevel
intervention research is a relatively new area of science
for NCI and so this conference is really designed to
get engagement from our stakeholders, both the
extramural research community and practioners, to really help
us move this science forward. And the imperative of
getting external input from our stakeholders is something that
is a real high priority to our director, Dr. Harold Varmus,
and it is something that we are taking very seriously both
in this initiative and in this conference. So what we
have done, as you can see on the slides, we have
identified three specific objectives to help structure
your input throughout the two day meeting. First, to
identify research needed to strengthen the foundation
for multilevel intervention research in healthcare. Second,
to understand the current state of science of multilevel
interventions across the cancer continuum. And third, to clarify
issues in the conceptualization of multilevel effects across
scientific disciplines. And I think as you will see
from the presentations that follow, these objectives
are really reflect some of the broad dimensions of multilevel
intervention research, conceptual challenges, research
design and methods and the breadth of research that is
inherent in this multi-method, multi-disciplinary
area of science. So what we have done to
accomplish these objectives is really structure
this conference, okay, to maximize discussion,
debate and active engagement among all of us
throughout the next two days. First, we have structured some
presentations that are very focused on particular topics
related to MLI research and each presenter will identify
some key questions that they believe are essential to
move this science forward. They will be followed by a
discussant who not only will remark on the questions
raised by the presenters, but possibly raise some
questions themselves. And then we move into what I
think is the most important part of this meeting
over the next two days, and that is where we have
audience discussions in small groups where you
will actively engage, both in thinking and responding
to the questions raised by presenters and discussants, but
also have the opportunity to raise your own issues and your
own questions based on your own experience, based on your
discipline and your particular area of research. And we are
very hopeful that with that we’ll be able to get the kind
of active engagement that will allow us all to participate
in answering some of the important questions in this
field. Then we will move to a question and answer session
where we have a moderator where one of their key
objectives is to connect with you and the presenters so they
will be able to, so you will be able to address those
questions which we hope will reflect some of the discussion
that you’ve had at your tables. And finally I just want to
mention that we do have poster presentations. We have
received several abstracts for this and the ones that were
awarded will be issued at the end of tomorrow in connection
with the reception. And while we’ll talk more
about that in the course of the meeting, please put that on
your agenda to make sure you attend and have a chance to
interact with your colleagues who are actually doing
related research in this field. So this is an
interactive session. There will be no knowledge
transfer solely in terms of people from this stage
imparting knowledge to you. This is about knowledge sharing
and active learning and we really hope you’re
ready to engage in this. So what do we want
from you? We want your active
involvement, okay? We want you to
take off your coats, roll up your sleeves, but sit
on the edge of your chairs and get ready to work. Because I
think that and I think also be prepared to maybe get out of
your comfort zone a little bit because we are going to ask
people to rotate tables to try to maximize the diverse input
on these important questions that will be raised today. We
are really excited to see the diverse of experience and
expertise that is represented in this room. And I think
honestly, if you are really willing to actively participate,
ask questions, raise issues, challenge assumptions, then I
think we have a really good chance of being successful in
this meeting achieving these objectives to better position
ourselves to move this field forward. Both in terms of
the work we do here at NCI, but also in terms of your
own interests in this area of research, whether or not
you are doing it in cancer. So one final point I want to
make before we start is that we have some authorization forms,
some of which you may have signed at the registration
desk, but others that are in your packet, that we really want
you to sign and return to us. That, first of all, acknowledge
that we are recording this session today, but also to
allow us to acknowledge your contribution to this particular
meeting by enabling us to acknowledge your work in
a supplement that will be published in the Journal of
the National Cancer Institute, which is a specific
product of this meeting.

About Bill McCormick

Read All Posts By Bill McCormick

Leave a Reply

Your email address will not be published. Required fields are marked *